Copyright © 2009 Christian Barbato et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. D. M. Skovronsky, V. M.-Y. Lee, and J. Q. Trojanowski, “Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications,” Annual Review of Pathology, vol. 1, pp. 151–170, 2006. View at Publisher · View at Google Scholar · View at PubMed
2. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar
3. K. S. Kosik, “The neuronal microRNA system,” Nature Reviews Neuroscience, vol. 7, no. 12, pp. 911–920, 2006. View at Publisher · View at Google Scholar · View at PubMed
4. C. Barbato, C. Giorgi, C. Catalanotto, and C. Cogoni, “Thinking about RNA? MicroRNAs in the brain,” Mammalian Genome, vol. 19, no. 7-8, pp. 541–551, 2008. View at Publisher · View at Google Scholar · View at PubMed
5. M. Selbach, B. Schwanhäusser, N. Thierfelder, Z. Fang, R. Khanin, and N. Rajewsky, “Widespread changes in protein synthesis induced by microRNAs,” Nature, vol. 455, no. 7209, pp. 58–63, 2008. View at Publisher · View at Google Scholar · View at PubMed
6. D. Baek, J. Villén, C. Shin, F. D. Camargo, S. P. Gygi, and D. P. Bartel, “The impact of microRNAs on protein output,” Nature, vol. 455, no. 7209, pp. 64–71, 2008. View at Publisher · View at Google Scholar · View at PubMed
7. E. Berezikov, F. Thuemmler, L. W. van Laake, et al., “Diversity of microRNAs in human and chimpanzee brain,” Nature Genetics, vol. 38, no. 12, pp. 1375–1377, 2006. View at Publisher · View at Google Scholar · View at PubMed
8. C. Haass and D. J. Selkoe, “Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid $\beta$-peptide,” Nature Reviews Molecular Cell Biology, vol. 8, no. 2, pp. 101–112, 2007. View at Publisher · View at Google Scholar · View at PubMed
9. H. Braak and E. Braak, “Neuropathological staging of Alzheimer-related changes,” Acta Neuropathologica, no. 82, pp. 239–259, 1991. View at Publisher · View at Google Scholar
10. W. J. Lukiw, “Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus,” NeuroReport, vol. 18, no. 3, pp. 297–300, 2007. View at Publisher · View at Google Scholar · View at PubMed
11. S. S. Hébert, K. Horré, L. Nicolaï, et al., “Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/$\beta$-secretase expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 17, pp. 6415–6420, 2008. View at Publisher · View at Google Scholar · View at PubMed
12. J. P. Cogswell, J. Ward, I. A. Taylor, et al., “Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways,” Journal of Alzheimer's Disease, vol. 14, no. 1, pp. 27–41, 2008.
13. P. Formichi, C. Battisti, E. Radi, and A. Federico, “Cerebrospinal fluid tau, A$\beta$, and phosphorylated tau protein for the diagnosis of Alzheimer's disease,” Journal of Cellular Physiology, vol. 208, no. 1, pp. 39–46, 2006. View at Publisher · View at Google Scholar · View at PubMed
14. W.-X. Wang, B. W. Rajeev, A. J. Stromberg, et al., “The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of $\beta$-site amyloid precursor protein-cleaving enzyme 1,” Journal of Neuroscience, vol. 28, no. 5, pp. 1213–1223, 2008. View at Publisher · View at Google Scholar · View at PubMed
15. V. Boissonneault, I. Plante, S. Rivest, and P. Provost, “MicroRNA-298 and microRNA-328 regulate expression of mouse $\beta$-amyloid precursor protein-converting enzyme 1,” Journal of Biological Chemistry, vol. 284, no. 4, pp. 1971–1981, 2009. View at Publisher · View at Google Scholar · View at PubMed
16. R. Niwa, F. Zhou, C. Li, and F. J. Slack, “The expression of the Alzheimer's amyloid precursor protein-like gene is regulated by developmental timing microRNAs and their targets in Caenorhabditis elegans,” Developmental Biology, vol. 315, no. 2, pp. 418–425, 2008. View at Publisher · View at Google Scholar · View at PubMed
17. N. Patel, D. Hoang, N. Miller, et al., “MicroRNAs can regulate human APP levels,” Molecular Neurodegeneration, vol. 3, no. 1, p. 10, 2008. View at Publisher · View at Google Scholar · View at PubMed
18. W. Mandemakers, V. A. Morais, and B. De Strooper, “A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases,” Journal of Cell Science, vol. 120, no. 10, pp. 1707–1716, 2007. View at Publisher · View at Google Scholar · View at PubMed
19. J. Kim, K. Inoue, J. Ishii, et al., “A microRNA feedback circuit in midbrain dopamine neurons,” Science, vol. 317, no. 5842, pp. 1220–1224, 2007. View at Publisher · View at Google Scholar · View at PubMed
20. G. Wang, J. M. van der Walt, G. Mayhew, et al., “Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of $\alpha$-Synuclein,” American Journal of Human Genetics, vol. 82, no. 2, pp. 283–289, 2008. View at Publisher · View at Google Scholar · View at PubMed
21. P. Siwach and S. Ganesh, “Tandem repeats in human disorders: mechanisms and evolution,” Frontiers in Bioscience, vol. 13, no. 12, pp. 4467–4484, 2008. View at Publisher · View at Google Scholar
22. J. M. Gil and A. C. Rego, “Mechanisms of neurodegeneration in Huntington's disease,” European Journal of Neuroscience, vol. 27, no. 11, pp. 2803–2820, 2008. View at Publisher · View at Google Scholar · View at PubMed
23. C. Conaco, S. Otto, J.-J. Han, and G. Mandel, “Reciprocal actions of REST and a microRNA promote neuronal identity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2422–2427, 2006. View at Publisher · View at Google Scholar · View at PubMed
24. R. Johnson, C. Zuccato, N. D. Belyaev, D. J. Guest, E. Cattaneo, and N. J. Buckley, “A microRNA-based gene dysregulation pathway in Huntington's disease,” Neurobiology of Disease, vol. 29, no. 3, pp. 438–445, 2008. View at Publisher · View at Google Scholar · View at PubMed
25. J. N. Savas, A. Makusky, S. Ottosen, et al., “Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 31, pp. 10820–10825, 2008. View at Publisher · View at Google Scholar · View at PubMed
26. F. Jiang, X. Ye, X. Liu, L. Fincher, D. McKearin, and Q. Liu, “Dicer-1 and R3D1-L catalyze microRNA maturation in Drosophila,” Genes and Development, vol. 19, no. 14, pp. 1674–1679, 2005. View at Publisher · View at Google Scholar · View at PubMed
27. J. Bilen, N. Liu, B. G. Burnett, R. N. Pittman, and N. M. Bonini, “MicroRNA pathways modulate polyglutamine-induced neurodegeneration,” Molecular Cell, vol. 24, no. 1, pp. 157–163, 2006. View at Publisher · View at Google Scholar · View at PubMed
28. A. Schaefer, D. O'Carroll, C. L. Tan, et al., “Cerebellar neurodegeneration in the absence of microRNAs,” Journal of Experimental Medicine, vol. 204, no. 7, pp. 1553–1558, 2007. View at Publisher · View at Google Scholar · View at PubMed
29. Y. Lee, R. C. Samaco, J. R. Gatchel, C. Thaller, H. T. Orr, and H. Y. Zoghbi, “miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis,” Nature Neuroscience, vol. 11, no. 10, pp. 1137–1139, 2008. View at Publisher · View at Google Scholar · View at PubMed
30. N. J. Cairns, E. H. Bigio, I. R. A. Mackenzie, et al., “Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration,” Acta Neuropathologica, vol. 114, no. 1, pp. 5–22, 2007. View at Publisher · View at Google Scholar · View at PubMed
31. R. Saba, C. D. Goodman, R. L. C. H. Huzarewich, C. Robertson, and S. A. Booth, “A miRNA signature of prion induced neurodegeneration,” PLoS ONE, vol. 3, no. 11, p. e3652, 2008. View at Publisher · View at Google Scholar · View at PubMed
32. R. Rademakers, J. L. Eriksen, M. Baker, et al., “Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia,” Human Molecular Genetics, vol. 17, no. 23, pp. 3631–3642, 2008. View at Publisher · View at Google Scholar · View at PubMed
33. A. Aguzzi, F. Baumann, and J. Bremer, “The prion's elusive reason for being,” Annual Review of Neuroscience, vol. 31, pp. 439–477, 2008. View at Publisher · View at Google Scholar · View at PubMed
34. G. Sorensen, S. Medina, D. Parchaliuk, C. Phillipson, C. Robertson, and S. A. Booth, “Comprehensive transcriptional profiling of prion infection in mouse models reveals networks of responsive genes,” BMC Genomics, vol. 9, article 114, 2008. View at Publisher · View at Google Scholar · View at PubMed
35. G. Meister, M. Landthaler, Y. Dorsett, and T. Tuschl, “Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing,” RNA, vol. 10, no. 3, pp. 544–550, 2004. View at Publisher · View at Google Scholar
36. M. S. Ebert, J. R. Neilson, and P. A. Sharp, “MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells,” Nature Methods, vol. 4, no. 9, pp. 721–726, 2007. View at Publisher · View at Google Scholar · View at PubMed